+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cystic Fibrosis Devices Market by Product, End User, Age Group, Therapy - Global Forecast 2025-2030- Product Image
Cystic Fibrosis Devices Market by Product, End User, Age Group, Therapy - Global Forecast 2025-2030- Product Image
Sale

Cystic Fibrosis Devices Market by Product, End User, Age Group, Therapy - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6014637
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cystic Fibrosis Devices Market grew from USD 2.93 billion in 2023 to USD 3.20 billion in 2024. It is expected to continue growing at a CAGR of 10.87%, reaching USD 6.04 billion by 2030.

Cystic fibrosis (CF) devices are indispensable in managing and treating cystic fibrosis - a genetic disorder affecting the respiratory and digestive systems. The market for CF devices encompasses a range of equipment such as nebulizers, inhalers, airway clearance systems, and other adjunctive therapies that aid in mucus clearance and improve respiratory function. The necessity of CF devices arises from the chronic nature of the disease, which requires long-term treatment to enhance patients' quality of life and increase life expectancy. Primarily used in hospitals, clinics, and home settings, these devices cater to both pediatric and adult populations, broadening their end-use scope. Key growth factors include a rise in the incidence of cystic fibrosis, technological advancements in device design, and increased awareness among healthcare providers and patients. The emergence of portable and user-friendly devices presents substantial opportunities, with potential expansion into developing markets seeking advanced healthcare solutions. However, growth is tempered by challenges such as high device costs, the need for regular maintenance, and the stringent regulatory landscape governing medical devices. Businesses must navigate these limitations while addressing the complex needs of CF patients. Innovation opportunities lie in the development of smart devices with integrated digital health technologies, which can provide real-time health monitoring and enhance patient adherence to treatment regimens. Additionally, advancing research in drug-device combination products could open new avenues for holistic therapy solutions. As the cystic fibrosis devices market evolves, companies should focus on collaboration with healthcare professionals to ensure that new products meet clinical needs and regulatory requirements. Furthermore, understanding regional variations in healthcare infrastructure and patient population demographics is crucial for strategic market entry and growth. Overall, the market is dynamic, driven by both medical necessity and technological innovation, offering substantial growth prospects amid existing constraints.

Understanding Market Dynamics in the Cystic Fibrosis Devices Market

The Cystic Fibrosis Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing awareness campaigns and government initiatives for early diagnosis of cystic fibrosis
    • Expansion of clinical trials and approval of new cystic fibrosis management devices
    • Collaborations between healthcare institutions and medical device manufacturers for cystic fibrosis solutions
    • Increasing adoption of personalized medicine approaches in the treatment of cystic fibrosis
  • Market Restraints
    • Stringent regulatory requirements and lengthy approval processes hindering the introduction of new devices
    • Limited funding and resources for research and development slowing innovation in cystic fibrosis care
  • Market Opportunities
    • Creation of digital platforms and mobile apps to enhance cystic fibrosis patient care and support
    • Integration of artificial intelligence in cystic fibrosis device diagnostics and monitoring
    • Establishment of specialized cystic fibrosis clinics with a multidisciplinary care approach
  • Market Challenges
    • Industry-specific challenge: addressing the limited patient population and ensuring market profitability for cystic fibrosis device manufacturers
    • Industry-specific challenge: integrating advanced technologies while maintaining affordability and user-friendliness in cystic fibrosis devices

Exploring Porter’s Five Forces for the Cystic Fibrosis Devices Market

Porter’s Five Forces framework further strengthens the insights of the Cystic Fibrosis Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cystic Fibrosis Devices Market

External macro-environmental factors deeply influence the performance of the Cystic Fibrosis Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cystic Fibrosis Devices Market

The Cystic Fibrosis Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cystic Fibrosis Devices Market

The Cystic Fibrosis Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cystic Fibrosis Devices Market

The Cystic Fibrosis Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cystic Fibrosis Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Allergan plc, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Chiesi Farmaceutici S.p.A., Cyclacel Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., GlaxoSmithKline plc, Mylan N.V., Novartis AG, Pfizer Inc., ProQR Therapeutics N.V., Proteostasis Therapeutics, Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Translate Bio, Inc., and Vertex Pharmaceuticals Incorporated.

Market Segmentation & Coverage

This research report categorizes the Cystic Fibrosis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Accessories
      • Masks
      • Sensors
      • Tubes
    • Devices
      • Airway Clearance Devices
      • High Frequency Chest Wall Oscillation Devices
      • Inhalers
      • Nebulizers
      • Positive Expiratory Pressure (PEP) Devices
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Homecare Settings
    • Hospitals
      • General Hospitals
      • Specialized Hospitals
  • Age Group
    • Adults
      • Older Adults
      • Young Adults
    • Geriatrics
    • Pediatrics
      • Children
      • Infants
  • Therapy
    • Nutritional Therapy
    • Pharmacotherapy
      • Antibiotics
      • Mucolytics
    • Physiotherapy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness campaigns and government initiatives for early diagnosis of cystic fibrosis
5.1.1.2. Expansion of clinical trials and approval of new cystic fibrosis management devices
5.1.1.3. Collaborations between healthcare institutions and medical device manufacturers for cystic fibrosis solutions
5.1.1.4. Increasing adoption of personalized medicine approaches in the treatment of cystic fibrosis
5.1.2. Restraints
5.1.2.1. Stringent regulatory requirements and lengthy approval processes hindering the introduction of new devices
5.1.2.2. Limited funding and resources for research and development slowing innovation in cystic fibrosis care
5.1.3. Opportunities
5.1.3.1. Creation of digital platforms and mobile apps to enhance cystic fibrosis patient care and support
5.1.3.2. Integration of artificial intelligence in cystic fibrosis device diagnostics and monitoring
5.1.3.3. Establishment of specialized cystic fibrosis clinics with a multidisciplinary care approach
5.1.4. Challenges
5.1.4.1. Industry-specific challenge: addressing the limited patient population and ensuring market profitability for cystic fibrosis device manufacturers
5.1.4.2. Industry-specific challenge: integrating advanced technologies while maintaining affordability and user-friendliness in cystic fibrosis devices
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cystic Fibrosis Devices Market, by Product
6.1. Introduction
6.2. Accessories
6.2.1. Masks
6.2.2. Sensors
6.2.3. Tubes
6.3. Devices
6.3.1. Airway Clearance Devices
6.3.2. High Frequency Chest Wall Oscillation Devices
6.3.3. Inhalers
6.3.4. Nebulizers
6.3.5. Positive Expiratory Pressure (PEP) Devices
7. Cystic Fibrosis Devices Market, by End User
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Clinics
7.4. Homecare Settings
7.5. Hospitals
7.5.1. General Hospitals
7.5.2. Specialized Hospitals
8. Cystic Fibrosis Devices Market, by Age Group
8.1. Introduction
8.2. Adults
8.2.1. Older Adults
8.2.2. Young Adults
8.3. Geriatrics
8.4. Pediatrics
8.4.1. Children
8.4.2. Infants
9. Cystic Fibrosis Devices Market, by Therapy
9.1. Introduction
9.2. Nutritional Therapy
9.3. Pharmacotherapy
9.3.1. Antibiotics
9.3.2. Mucolytics
9.4. Physiotherapy
10. Americas Cystic Fibrosis Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cystic Fibrosis Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cystic Fibrosis Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CYSTIC FIBROSIS DEVICES MARKET RESEARCH PROCESS
FIGURE 2. CYSTIC FIBROSIS DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CYSTIC FIBROSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CYSTIC FIBROSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CYSTIC FIBROSIS DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CYSTIC FIBROSIS DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MASKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AIRWAY CLEARANCE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HIGH FREQUENCY CHEST WALL OSCILLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY POSITIVE EXPIRATORY PRESSURE (PEP) DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NUTRITIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 76. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 78. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 79. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 83. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 84. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 85. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 128. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 130. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 131. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 134. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 135. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 136. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 137. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 138. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 140. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 141. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 144. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 145. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 146. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 147. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 158. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 160. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 161. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 163. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 165. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 166. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 167. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 186. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 196. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 216. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 218. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 220. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 221. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 225. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 226. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 227. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 236. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 249. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 251. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 252. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 255. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 258. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 259. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 261. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 262. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 266. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 267. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 268. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 269. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 271. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 272. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 274. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 275. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 276. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 277. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 278. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 279. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 280. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 281. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 282. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 284. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 285. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 286. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 287. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 288. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 289. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 290. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 291. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 292. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 294. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 295. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 296. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 297. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 298. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 307. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 308. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 309. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 311. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 312. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 314. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 315. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 316. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 317. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 318. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 339. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 340. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 341. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 342. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITAL

Companies Mentioned

The leading players in the Cystic Fibrosis Devices Market, which are profiled in this report, include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan plc
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici S.p.A.
  • Cyclacel Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • ProQR Therapeutics N.V.
  • Proteostasis Therapeutics, Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Translate Bio, Inc.
  • Vertex Pharmaceuticals Incorporated

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.04 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Cystic Fibrosis Devices - Global Strategic Business Report - Product Image

Cystic Fibrosis Devices - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis Market Report 2024 - Product Image

Non-Cystic Fibrosis Bronchiectasis Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Cystic Fibrosis Market Analysis & Forecast to 2024-2034 - Product Image

Cystic Fibrosis Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Cystic Fibrosis Market - Forecasts from 2024 to 2029 - Product Image

Cystic Fibrosis Market - Forecasts from 2024 to 2029

  • Report
  • 145 Pages
  • Global
From

About the Cystic Fibrosis Devices Market

The Cystic Fibrosis Devices market is a subset of the larger Respiratory Devices market. It includes devices used to diagnose, monitor, and treat cystic fibrosis, a genetic disorder that affects the lungs and digestive system. Diagnostic devices include sweat chloride tests and genetic tests, while monitoring devices include spirometers and pulse oximeters. Treatment devices include nebulizers, inhalers, and airway clearance systems. These devices are used to help manage the symptoms of cystic fibrosis, such as coughing, wheezing, and difficulty breathing. Some companies in the Cystic Fibrosis Devices market include Philips Respironics, ResMed, and Fisher & Paykel Healthcare. Other companies include Inogen, Invacare, and Vyaire Medical. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.